CAS: 1509916-03-3
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Cergutuzumab REF: 3D-CLA1643CAS: 1509916-03-3 | - - - | A consultar | Vie 20 Dic 24 | |
Cergutuzumab Amunaleukin REF: 3D-CLA1643ACAS: 1509916-03-3 | - - - | A consultar | Vie 20 Dic 24 | |
Cergutuzumab amunaleukin REF: TM-T76944CAS: 1509916-03-3 | 99.7% (SEC-HPLC) - 99.7% (SEC-HPLC) | 389,00 €~3.238,00 € | Lun 10 Feb 25 |
Cergutuzumab
CAS:1509916-03-3
Cergutuzumab amunaleukin (CEA-IL2v) is an immunocytokine directed against carcinoembryonic antigen (CEA) containing an IL2v-moiety with …
Ref: 3D-CLA1643
Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Viernes 20 de Diciembre de 2024
Cergutuzumab Amunaleukin
CAS:1509916-03-3
Cergutuzumab amunaleukin (CEA-IL2v) is an immunocytokine directed against carcinoembryonic antigen (CEA) containing an IL2v-moiety with …
Ref: 3D-CLA1643A
Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Viernes 20 de Diciembre de 2024
Cergutuzumab amunaleukin
CAS:1509916-03-3
Cergutuzumab amunaleukin (CEA-IL2v) is a CEA-targeted IL-2 variant immunocytokine for combination cancer immunotherapy with anti-tumor …
Pureza:
99.7% (SEC-HPLC) - 99.7% (SEC-HPLC)
Forma y color:
Liquid
Peso molecular:
162.05 kDa
Ref: TM-T76944
1mg | 389,00 € | ||
5mg | 989,00 € | ||
10mg | 1.615,00 € | ||
25mg | 2.385,00 € | ||
50mg | 3.238,00 € |
Entrega estimada en Estados Unidos, el Lunes 10 de Febrero de 2025